NCNA
NuCana Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.98
−1.30%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$2.65
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.99
- EPS estimate
- -$2.65
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +64.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$2.65 | -$0.99 | Beat 62.66% | — |
| May 14, 2026 | -$2.64 | -$1.25 | Beat 52.72% | — |
| Mar 19, 2026 | -$2.69 | -$1.47 | Beat 45.44% | — |
| Nov 13, 2025 | -$2.69 | -$0.10 | Beat 96.28% | — |
| Aug 20, 2025 | -$2.75 | -$0.16 | Beat 94.17% | — |
| Jun 2, 2025 | -$2.58 | -$126 | Miss -4778.05% | — |
| Mar 20, 2025 | -$486 | -$64 | Beat 86.83% | — |
| Nov 25, 2024 | -$3.47 | -$456 | Miss -13041.21% | — |
| Aug 15, 2024 | -$710 | -$758 | Miss -6.76% | — |
| May 16, 2024 | -$662 | -$32 | Beat 95.17% | — |
| Mar 20, 2024 | -$650 | -$850 | Miss -30.77% | — |
| Nov 16, 2023 | -$650 | -$800 | Miss -23.08% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026